Nat Rev Cancer. 2009 Jun;9(6):415-28.

The biology of ovarian cancer: new opportunities for translation.

Source

Departments of Experimental Therapeutics and Systems Biology, University of Texas M. D. Anderson Cancer Center, 1515 Holcolmbe Boulevard, Houston, TX 77030, USA. rbast@mdanderson.org

Abstract

Over the past two decades, the 5-year survival for ovarian cancer patients has substantially improved owing to more effective surgery and treatment with empirically optimized combinations of cytotoxic drugs, but the overall cure rate remains approximately 30%. Many investigators think that further empirical trials using combinations of conventional agents are likely to produce only modest incremental improvements in outcome. Given the heterogeneity of this disease, increases in long-term survival might be achieved by translating recent insights at the molecular and cellular levels to personalize individual strategies for treatment and to optimize early detection.

PMID:: 19461667; [PubMed - indexed for MEDLINE]
PMCID:: PMC2814299

Free PMC Article

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Antineoplastic Agents

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Review A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer. [Health Technol Assess. 2001]
Review A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N. Health Technol Assess. 2001; 5(32):1-195.
Review Molecular targeted therapy in ovarian cancer: what is on the horizon? [Drugs. 2011]
Review Molecular targeted therapy in ovarian cancer: what is on the horizon?
Kalachand R, Hennessy BT, Markman M. Drugs. 2011 May 28; 71(8):947-67.
Review Relapsed ovarian cancer: challenges and management strategies for a chronic disease. [Oncologist. 2002]
Review Relapsed ovarian cancer: challenges and management strategies for a chronic disease.
Armstrong DK. Oncologist. 2002; 7 Suppl 5:20-8.
Review Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation. [Health Technol Assess. 2006]
Review Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R. Health Technol Assess. 2006 Mar; 10(9):1-132. iii-iv.
Review Investigational agents for epithelial ovarian cancer. [Expert Rev Anticancer Ther. 2005]
Review Investigational agents for epithelial ovarian cancer.
Muggia F, Kosloff R. Expert Rev Anticancer Ther. 2005 Oct; 5(5):855-68.

See reviews... See all...

Cited by 52 PubMed Central articles

Understanding and overcoming chemoresistance in ovarian cancer: emerging role of the endothelin axis. [Curr Oncol. 2012]
Understanding and overcoming chemoresistance in ovarian cancer: emerging role of the endothelin axis.
Bagnato A, Rosanò L. Curr Oncol. 2012 Feb; 19(1):36-8.
An orthotopic model of platinum-sensitive high grade serous fallopian tube carcinoma. [Int J Clin Exp Pathol. 2012]
An orthotopic model of platinum-sensitive high grade serous fallopian tube carcinoma.
Khabele D, Fadare O, Liu AY, Wilson AJ, Wass E, Osteen K, Crispens MA. Int J Clin Exp Pathol. 2012; 5(1):37-45. Epub 2011 Jan 1.
Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4. [Neoplasia. 2011]
Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4.
Ray P, Lewin SA, Mihalko LA, Schmidt BT, Luker KE, Luker GD. Neoplasia. 2011 Dec; 13(12):1152-61.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The biology of ovarian cancer: new opportunities for translation.
The biology of ovarian cancer: new opportunities for translation.
Nat Rev Cancer. 2009 Jun ;9(6):415-28.

PubMed
Delayed recovery of renal function in patients with acute renal failure due to a...
Delayed recovery of renal function in patients with acute renal failure due to accelerated hypertension.
Postgrad Med J. 1991 Sep ;67(791):829-32.

PubMed
Language interpreting as social justice work: perspectives of formal and informa...
Language interpreting as social justice work: perspectives of formal and informal healthcare interpreters.
ANS Adv Nurs Sci. 2009 Apr-Jun ;32(2):128-43.

PubMed
Informational needs and selected variables in patients receiving brachytherapy.
Informational needs and selected variables in patients receiving brachytherapy.
Oncol Nurs Forum. 1991 Sep-Oct ;18(7):1221-7; discussion 1227-9.

PubMed
Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular l...
Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice.
Clin Exp Nephrol. 2009 Oct ;13(5):430-7. Epub 2009 May 21 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: